{"gene":"FCER1A","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1997,"finding":"Site-directed mutagenesis of soluble FcεRIα identified K117 in the second immunoglobulin-like domain as a critical contact residue for IgE binding; K117D reduced IgE-binding affinity ~30-fold, and D159K increased affinity ~7-fold, both primarily through changes in dissociation rates, defining the IgE contact surface on FcεRIα.","method":"Site-directed mutagenesis + surface plasmon resonance (SPR) binding kinetics + circular dichroism","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis with quantitative SPR kinetics and structural validation by CD","pmids":["9398286"],"is_preprint":false},{"year":1998,"finding":"IgE binding to FcεRIα upregulates cell-surface FcεRIα expression on human basophils in vitro in a dose-dependent manner; this upregulation requires IgE interaction through FcεRIα itself (blocked by anti-FcεRIα mAb CGP51901 and inhibited by dimeric IgE), and follows a linear time course over two weeks.","method":"Flow cytometry, Western blotting of whole-cell lysates, in vitro basophil culture with IgE","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (flow cytometry + Western blot + pharmacological blocking), moderate evidence","pmids":["9473229"],"is_preprint":false},{"year":1998,"finding":"Anti-FcεRIα IgG autoantibodies in chronic urticaria patients activate basophil histamine release via complement (C5a receptor pathway); IgG1/IgG3 complement-fixing subtypes mediate this activity, and C5a receptor blockade or decomplementation drastically reduces histamine-releasing capacity.","method":"ELISA, Western blotting, histamine release assay, C5a receptor blockade, decomplementation","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal functional assays with pharmacological inhibition, strong mechanistic conclusion","pmids":["9421487"],"is_preprint":false},{"year":1996,"finding":"Chimeric receptor experiments in RBL-2H3 cells showed that both the extracellular domain of FcεRIα and the cytoplasmic tail of FcεRIγ are essential for FcεRI-mediated signaling (inositol phosphate production, tyrosine phosphorylation, Ca2+ mobilization, histamine and arachidonic acid metabolite secretion); FcεRIα extracellular domain also modulates the magnitude of signaling events.","method":"Chimeric receptor expression in RBL-2H3 cells, inositol phosphate assay, tyrosine phosphorylation, Ca2+ mobilization, histamine/arachidonic acid secretion","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — domain-swap epistasis with multiple functional readouts in cell-based system","pmids":["8648137"],"is_preprint":false},{"year":2001,"finding":"The IgE Cε2 domain contributes to the exceptionally long half-life of the IgE–FcεRIα complex; deletion of Cε2 from IgE Fc increases the dissociation rate from FcεRIα by >10-fold; NMR chemical shift perturbation showed Cε2 interacts directly with FcεRIα, and sedimentation equilibrium showed Cε2 also binds the Cε3-4 fragment.","method":"NMR (heteronuclear) structure determination, chemical shift perturbation, sedimentation equilibrium, dissociation kinetics","journal":"Nature structural biology","confidence":"High","confidence_rationale":"Tier 1 — NMR structure plus functional deletion assay and biophysical binding measurements","pmids":["11323720"],"is_preprint":false},{"year":2001,"finding":"FcεRIα exists in two glycosylation states on basophils (50 kDa and 60 kDa bands); the 60 kDa band correlates with surface-expressed FcεRIα, and FcεRIβ protein levels correlate with surface FcεRIα (Spearman R=0.92), demonstrating variable FcεRIα:β stoichiometry that can be altered by IL-3 culture.","method":"Western blotting, flow cytometry, real-time PCR, IL-3 culture","journal":"The Journal of allergy and clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods, single laboratory","pmids":["11344350"],"is_preprint":false},{"year":2000,"finding":"Upregulation of FcεRIα by IgE on basophils increases responsiveness to antigenic challenge (enhanced histamine and IL-4 release at suboptimal antigen concentrations) but is not always accompanied by coordinated upregulation of all IgE-signaling pathway components, indicating that functional upregulation can be modulated independently.","method":"Basophil culture with IgE, flow cytometry, histamine and IL-4 secretion assays, antigen dose-response","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — clean functional KD/KO equivalent (receptor density manipulation) with defined cellular phenotype","pmids":["11037968"],"is_preprint":false},{"year":2002,"finding":"Mutagenesis of human FcεRIα combined with the crystal structure identified three residues in the C-C' region of the α2 domain (K117, W130, Y131) and two in the α1 domain (R15, F17) as important for IgE binding; K117 and W130 have different effects on human vs. mouse IgE binding, indicating species-specific contact differences.","method":"Site-directed mutagenesis, SPR binding assays with human and mouse IgE","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis with quantitative binding kinetics, uses crystal structure context","pmids":["11823511"],"is_preprint":false},{"year":2003,"finding":"Monomeric IgE stabilizes FcεRIα on basophils (KU812 cell line) by protecting it from temperature-dependent lysosomal turnover, without inducing intracellular signaling (no tyrosine phosphorylation or Ca2+ release); only cross-linked IgE triggers signaling.","method":"Flow cytometry, Western blotting, immunoradiometric assay, Ca2+ fluorescence (Fura-2), tyrosine phosphorylation assay","journal":"Clinical and experimental allergy","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods distinguishing signaling from stabilization, in vitro reconstitution","pmids":["12752595"],"is_preprint":false},{"year":2006,"finding":"The FcεRIα promoter polymorphism -344C>T increases promoter activity in mast cells (RBL-2H3 luciferase reporter assay), and the -344C allele preferentially binds transcription factor Myc-associated zinc finger protein (MAZ) as shown by EMSA, providing a molecular mechanism for differential FcεRIα expression.","method":"Luciferase reporter assay, electrophoretic mobility shift assay (EMSA)","journal":"The Journal of allergy and clinical immunology","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay (reporter) plus direct protein-DNA binding (EMSA)","pmids":["17125826"],"is_preprint":false},{"year":2006,"finding":"IgE-Fc (Fcε) undergoes an unfolding transition at pH below 5.0 in its Cε3-Cε4 receptor-binding domains that abrogates interaction with FcεRIα; at neutral and mildly acidic pH (≥5.5) high-affinity binding is maintained, but interaction is lost at pH <5.0.","method":"Circular dichroism, differential scanning calorimetry, isothermal titration calorimetry, SPR-based binding assay at varying pH","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple biophysical methods with structural and binding data","pmids":["16905745"],"is_preprint":false},{"year":2009,"finding":"The FcεRIα distal promoter polymorphism -18483A>C (rs2494262) affects transcriptional activity through differential binding of the YY1 transcription factor; the -18483C allele preferentially binds YY1, resulting in lower transcriptional activity compared to the -18483A allele.","method":"EMSA (YY1 binding preference), luciferase reporter assay","journal":"Immunogenetics","confidence":"High","confidence_rationale":"Tier 1 — direct protein-DNA binding (EMSA) plus functional reporter assay","pmids":["19685047"],"is_preprint":false},{"year":2014,"finding":"Transcription factors PU.1, GATA1, and GATA2 are required for FcεRIα (FCER1A) expression in human mast cells; ChIP showed all three bind the FCER1A promoter; siRNA knockdown of each reduces FcεRIα mRNA and surface expression, and GATA2 additionally transactivates FcεRIβ (MS4A2) promoter via direct binding verified by EMSA and luciferase assay. Knockdown of these factors also suppresses IgE-mediated degranulation.","method":"siRNA knockdown, ChIP, luciferase reporter assay, EMSA, flow cytometry, real-time PCR, degranulation assay in LAD2 cells and primary mast cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (ChIP, EMSA, reporter, functional assay) in multiple cell systems","pmids":["24639354"],"is_preprint":false},{"year":1998,"finding":"The membrane-proximal FG loop (residues 154-165) of FcεRIα contributes to IgE binding; W156A mutation abolishes binding of inhibitory mAb 15/1 (which competes with IgE) but does not affect IgE binding itself, indicating distinct but overlapping epitopes within this structural motif.","method":"Site-directed mutagenesis, binding assays, peptide library phage display for epitope mapping","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional binding assays, single laboratory","pmids":["9883889"],"is_preprint":false},{"year":2010,"finding":"Both IgE-dependent (anti-IgE) and IgE-independent stimulation (FMLP, C5a) of human basophils increases the immature intracellular form of FcεRIα (p46) by reversing lysosomal degradative pathways rather than increasing synthesis; IL-3 increases FcεRIα by enhancing synthesis via a distinct pathway (synergy with bafilomycin A).","method":"Western blotting, quantitative PCR, pulse-chase labeling, lysosomal inhibitor (bafilomycin A) treatment","journal":"International archives of allergy and immunology","confidence":"Medium","confidence_rationale":"Tier 2 — pulse-chase plus pharmacological dissection of pathway, single laboratory","pmids":["20664273"],"is_preprint":false},{"year":2013,"finding":"Anti-FcεRIα mAb rapid desensitization suppresses IgE-mediated anaphylaxis in mice by first decreasing mast cell FcεRI signaling, then inducing mast cell unresponsiveness by removing membrane FcεRI; this approach is safer and more durable than antigen desensitization.","method":"Mouse anaphylaxis models (active and passive), flow cytometry, histamine/mast cell protease release assays, cytokine measurement, calcium flux","journal":"The Journal of allergy and clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular mechanism with multiple readouts in vivo and in vitro, single group","pmids":["23632296"],"is_preprint":false},{"year":2019,"finding":"FcεRIα surface expression levels correlate with co-expression of FcεRIγ in RBL reporter cell lines; stable transfection with FcεRIγ increases FcεRIα surface expression, indicating that FcεRIγ co-expression post-translationally promotes FcεRIα surface trafficking independent of gene copy number or mRNA levels.","method":"Flow cytometry with calibration microspheres, qPCR, RT-qPCR, stable transfection","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — rescue experiment with functional transfection, multiple quantitative methods","pmids":["31430311"],"is_preprint":false},{"year":2022,"finding":"FcεRIα is expressed in a subpopulation of conjunctival sensory (trigeminal) neurons; IgE-immune complex directly activates these neurons and evokes ocular itch independently of conjunctival mast cell activation; neuronal-specific knockdown of FcεRIα (via AAV) significantly reduces ocular itch in an OVA-induced allergic conjunctivitis model without affecting immune cell infiltration.","method":"Calcium imaging, global FcεRIα KO mice, AAV-mediated neuronal-specific FcεRIα knockdown, behavioral itch assays, immunohistochemistry, Western blot, RT-PCR","journal":"Journal of neuroinflammation","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific genetic knockdown with behavioral and mechanistic readouts, multiple orthogonal methods","pmids":["35197064"],"is_preprint":false},{"year":2023,"finding":"A natural antisense transcript (FCER1A-AS) co-expressed with FCER1A-S is required for sense transcript and FcεRIα protein expression in mast cells; CasRx-mediated knockdown of FCER1A-AS markedly decreases FCER1A-S mRNA and FcεRIα protein; FCER1A-AS-deficient mice phenocopy FcεRIα knockout mice in Schistosoma infection survival and IgE-mediated cutaneous anaphylaxis.","method":"CRISPR/CasRx knockdown, in vivo FCER1A-AS knockout mice, Schistosoma infection model, passive cutaneous anaphylaxis model, RT-PCR, Western blot","journal":"Microbiology spectrum","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with genetic rescue and in vivo phenocopy, multiple orthogonal methods","pmids":["37154775"],"is_preprint":false},{"year":2025,"finding":"YH35324, a hybrid FcεRIα extracellular domain protein, binds IgE-unoccupied FcεRIα on mast cells (LAD2), is internalized via actin-dependent endocytosis, recycled via FcRn binding in lysosomes, and suppresses FcεRIα surface expression more effectively than omalizumab in basophils from allergic patients.","method":"Flow cytometry, immunoblot, immunocytochemistry, ELISA, pharmacological inhibition of endocytosis, FcRn binding assay","journal":"Allergy, asthma & immunology research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods defining internalization pathway, single laboratory","pmids":["40204504"],"is_preprint":false},{"year":2001,"finding":"GM-CSF dose- and time-dependently reduces FcεRIα mRNA and protein expression in human mast cells (HMC-1 and cord blood-derived mast cells) in vitro, accompanied by decreased histamine levels and tryptase activity, demonstrating that GM-CSF selectively inhibits mast cell differentiation markers including FcεRIα.","method":"mRNA analysis, immunoreactivity staining, intracellular histamine/tryptase assay, in vitro mast cell culture","journal":"Archives of dermatological research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple readouts in two cell systems, single laboratory","pmids":["11409570"],"is_preprint":false},{"year":2014,"finding":"CD72 agonistic antibody (K10.6) induces phosphorylation of the ubiquitin ligase Cbl-b and decreases FcεRIα (and KIT) surface expression on mouse bone marrow-derived mast cells, suppressing IgE-triggered degranulation; this mechanism is species-dependent (different from human mast cells where CD72 does not suppress IgE/FcεRI responses).","method":"Flow cytometry, Western blotting (Cbl-b phosphorylation), IgE-triggered degranulation assay, agonistic antibody treatment","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway identification with functional readout, single laboratory","pmids":["25239131"],"is_preprint":false}],"current_model":"FcεRIα is the IgE-binding α-subunit of the tetrameric high-affinity IgE receptor (FcεRI); its second extracellular immunoglobulin-like domain (particularly K117, W130, Y131) and membrane-proximal regions form the IgE contact surface, while the IgE Cε2 domain stabilizes the complex and slows dissociation; surface expression is transcriptionally controlled by PU.1, GATA1, and GATA2, post-transcriptionally stabilized by monomeric IgE through prevention of lysosomal turnover, regulated by a co-expressed natural antisense transcript (FCER1A-AS), and requires co-expression of FcεRIγ for efficient surface trafficking; FcεRIα mediates mast cell and basophil activation upon IgE cross-linking (requiring both its extracellular domain and the FcεRIγ cytoplasmic tail for full signaling), and also functions directly in sensory neurons to mediate IgE-IC-evoked itch independently of mast cells."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing that FcεRIα's extracellular domain and FcεRIγ's cytoplasmic tail are both required for full IgE-mediated signaling resolved the division of labor within the receptor complex — ligand recognition versus signal transduction.","evidence":"Chimeric receptor domain-swap experiments in RBL-2H3 cells with multiple functional readouts (IP production, Ca²⁺, degranulation)","pmids":["8648137"],"confidence":"High","gaps":["No structural model of α–γ interface","Contribution of FcεRIβ to signaling not resolved in this system"]},{"year":1997,"claim":"Identification of K117 as a critical IgE-contact residue defined the molecular binding interface on FcεRIα's α2 domain and showed that affinity is governed primarily by dissociation kinetics.","evidence":"Site-directed mutagenesis of soluble FcεRIα with quantitative SPR kinetics","pmids":["9398286"],"confidence":"High","gaps":["Full binding footprint not yet mapped","No crystal structure of complex at this time"]},{"year":1998,"claim":"Demonstrating that IgE itself upregulates FcεRIα surface expression on basophils established a positive-feedback loop between circulating IgE and receptor density, directly relevant to allergic sensitization.","evidence":"Flow cytometry and Western blot of basophils cultured with graded IgE concentrations, with anti-FcεRIα blocking","pmids":["9473229"],"confidence":"High","gaps":["Mechanism of upregulation (stabilization vs. synthesis) not yet distinguished","In vivo confirmation lacking"]},{"year":2001,"claim":"Showing that the IgE Cε2 domain directly contacts FcεRIα and slows dissociation >10-fold explained the exceptionally long half-life of the IgE–FcεRI complex.","evidence":"NMR chemical shift perturbation, sedimentation equilibrium, and dissociation kinetics of Cε2-deleted IgE-Fc","pmids":["11323720"],"confidence":"High","gaps":["Atomic-resolution structure of Cε2–FcεRIα interface not determined","Role of Cε2 in allergen cross-linking geometry unknown"]},{"year":2002,"claim":"Expanding the IgE contact map to W130 and Y131 and demonstrating species-specific differences refined the binding-surface model and informed therapeutic targeting of the α2 domain.","evidence":"Crystal-structure-guided mutagenesis with SPR using human and mouse IgE","pmids":["11823511"],"confidence":"High","gaps":["Energetic contributions of individual contacts not fully decomposed","No co-crystal with bound IgE at atomic resolution at this point"]},{"year":2003,"claim":"Distinguishing stabilization from signaling resolved how monomeric IgE increases FcεRIα density: IgE protects FcεRIα from lysosomal degradation without triggering activation, whereas only cross-linked IgE initiates signaling.","evidence":"Flow cytometry, Ca²⁺ flux, tyrosine phosphorylation assays, and lysosomal degradation studies in KU812 cells","pmids":["12752595"],"confidence":"High","gaps":["Exact lysosomal sorting signals on FcεRIα not identified","Whether stabilization involves conformational change or steric shielding unresolved"]},{"year":2006,"claim":"Identifying the -344C>T promoter polymorphism and its differential binding of transcription factor MAZ provided the first molecular mechanism for genetically encoded variation in FcεRIα expression levels.","evidence":"Luciferase reporter assay and EMSA in RBL-2H3 cells","pmids":["17125826"],"confidence":"High","gaps":["In vivo relevance to atopic disease risk not functionally validated","Interaction with other promoter-bound factors not examined"]},{"year":2014,"claim":"Demonstrating that PU.1, GATA1, and GATA2 each bind the FCER1A promoter and are individually required for FcεRIα expression and IgE-mediated degranulation established the core transcription factor network controlling receptor expression in human mast cells.","evidence":"ChIP, EMSA, luciferase reporter, siRNA knockdown with flow cytometry and degranulation assays in LAD2 and primary mast cells","pmids":["24639354"],"confidence":"High","gaps":["Combinatorial logic of PU.1/GATA cooperativity not dissected","Epigenetic regulation of the locus not addressed"]},{"year":2019,"claim":"Showing that FcεRIγ co-expression is required for efficient FcεRIα surface trafficking independently of mRNA levels resolved the post-translational bottleneck in receptor assembly.","evidence":"Stable transfection of FcεRIγ into RBL reporter cells with calibrated flow cytometry and qPCR","pmids":["31430311"],"confidence":"Medium","gaps":["Direct α–γ interaction interface not mapped","Role of FcεRIβ in trafficking not examined in this system"]},{"year":2022,"claim":"Discovery that FcεRIα is expressed on trigeminal sensory neurons and directly mediates IgE-immune-complex-evoked itch independently of mast cells expanded the receptor's functional repertoire beyond immune cells.","evidence":"Calcium imaging, global FcεRIα KO mice, AAV-mediated neuronal-specific knockdown, and behavioral itch assays in allergic conjunctivitis model","pmids":["35197064"],"confidence":"High","gaps":["Downstream neuronal signaling pathway not defined","Whether neuronal FcεRI contains β/γ subunits unknown","Relevance to non-ocular itch or pain not tested"]},{"year":2023,"claim":"Establishing that a natural antisense transcript (FCER1A-AS) is essential for FCER1A sense mRNA and protein expression — with knockout mice phenocopying FcεRIα deficiency — revealed a non-coding RNA layer of receptor regulation.","evidence":"CasRx knockdown in mast cells plus FCER1A-AS knockout mice tested in Schistosoma infection and passive cutaneous anaphylaxis models","pmids":["37154775"],"confidence":"High","gaps":["Mechanism of antisense-mediated stabilization (RNA duplex, chromatin, or splicing) not defined","Tissue specificity of antisense regulation not characterized"]},{"year":null,"claim":"Key unresolved questions include the atomic-resolution mechanism by which FCER1A-AS stabilizes sense mRNA, the downstream signaling pathway in sensory neurons, the structural basis of the FcεRIα–γ assembly interaction, and whether neuronal FcεRI assembles with β and γ subunits.","evidence":"","pmids":[],"confidence":"Low","gaps":["Neuronal FcεRI subunit composition unknown","Antisense RNA mechanism of action uncharacterized","No high-resolution structure of full tetrameric receptor in membrane context"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,3,7,17]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,5,6,16,19]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[8,14]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,3,6,12,15,17]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,6,8,17]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[9,11,12,18]}],"complexes":["FcεRI (high-affinity IgE receptor tetramer: αβγ2)"],"partners":["FCER1G","MS4A2","IGHE","PU.1","GATA1","GATA2","MAZ","YY1"],"other_free_text":[]},"mechanistic_narrative":"FCER1A encodes the IgE-binding α-subunit of the high-affinity IgE receptor (FcεRI), serving as the primary determinant of IgE recognition on mast cells, basophils, and a subset of sensory neurons, thereby coupling humoral IgE to cellular effector responses in allergy and immunity. The IgE-binding interface maps to the second extracellular immunoglobulin-like domain — particularly residues K117, W130, and Y131 — while the IgE Cε2 domain stabilizes the complex by slowing dissociation more than 10-fold [PMID:9398286, PMID:11823511, PMID:11323720]. Surface expression of FcεRIα is transcriptionally driven by PU.1, GATA1, and GATA2 and post-transcriptionally stabilized by monomeric IgE, which prevents lysosomal turnover without triggering signaling; efficient surface trafficking additionally requires co-expression of FcεRIγ, and a co-expressed natural antisense transcript (FCER1A-AS) is essential for sense mRNA and protein production [PMID:24639354, PMID:12752595, PMID:31430311, PMID:37154775]. Beyond canonical mast cell/basophil activation, FcεRIα expressed on trigeminal sensory neurons directly mediates IgE-immune-complex-evoked itch independently of mast cells [PMID:35197064]."},"prefetch_data":{"uniprot":{"accession":"P12319","full_name":"High affinity immunoglobulin epsilon receptor subunit alpha","aliases":["Fc-epsilon RI-alpha","FcERI","IgE Fc receptor subunit alpha"],"length_aa":257,"mass_kda":29.6,"function":"High-affinity receptor for immunoglobulin epsilon/IgE. Mediates IgE effector functions in myeloid cells. Upon IgE binding and antigen/allergen cross-linking initiates signaling pathways that lead to myeloid cell activation and differentiation. On mast cells, basophils and eosinophils stimulates the secretion of vasoactive amines, lipid mediators and cytokines that contribute to inflammatory response, tissue remodeling and cytotoxicity against microbes. Triggers the immediate hypersensitivity response to allergens as a host defense mechanism against helminth parasites, pathogenic bacteria and venom toxicity. When dysregulated, it can elicit harmful life-threatening allergic and anaphylactic reactions","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P12319/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FCER1A","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FCER1A","total_profiled":1310},"omim":[{"mim_id":"620483","title":"VARIEGATE PORPHYRIA, CHILDHOOD-ONSET; VPCO","url":"https://www.omim.org/entry/620483"},{"mim_id":"616082","title":"FERRY ENDOSOMAL RAB5 EFFECTOR COMPLEX SUBUNIT 3; FERRY3","url":"https://www.omim.org/entry/616082"},{"mim_id":"611434","title":"CYTOKINE-DEPENDENT HEMATOPOIETIC CELL LINKER; CLNK","url":"https://www.omim.org/entry/611434"},{"mim_id":"605484","title":"Fc FRAGMENT OF IgA AND IgM, RECEPTOR FOR; FCAMR","url":"https://www.omim.org/entry/605484"},{"mim_id":"605084","title":"MITOCHONDRIAL CALCIUM UPTAKE PROTEIN 1; MICU1","url":"https://www.omim.org/entry/605084"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"skin 1","ntpm":35.1}],"url":"https://www.proteinatlas.org/search/FCER1A"},"hgnc":{"alias_symbol":["FcepsilonRIalpha","FCERIA"],"prev_symbol":["FCE1A"]},"alphafold":{"accession":"P12319","domains":[{"cath_id":"2.60.40.10","chopping":"30-111","consensus_level":"medium","plddt":91.5076,"start":30,"end":111},{"cath_id":"2.60.40.10","chopping":"112-203","consensus_level":"medium","plddt":94.3922,"start":112,"end":203}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P12319","model_url":"https://alphafold.ebi.ac.uk/files/AF-P12319-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P12319-F1-predicted_aligned_error_v6.png","plddt_mean":84.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FCER1A","jax_strain_url":"https://www.jax.org/strain/search?query=FCER1A"},"sequence":{"accession":"P12319","fasta_url":"https://rest.uniprot.org/uniprotkb/P12319.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P12319/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P12319"}},"corpus_meta":[{"pmid":"18846228","id":"PMC_18846228","title":"Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18846228","citation_count":212,"is_preprint":false},{"pmid":"9421487","id":"PMC_9421487","title":"Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.","date":"1998","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9421487","citation_count":203,"is_preprint":false},{"pmid":"9473229","id":"PMC_9473229","title":"In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9473229","citation_count":119,"is_preprint":false},{"pmid":"17125826","id":"PMC_17125826","title":"Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria.","date":"2006","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17125826","citation_count":92,"is_preprint":false},{"pmid":"11323720","id":"PMC_11323720","title":"The structure of the IgE Cepsilon2 domain and its role in stabilizing the complex with its high-affinity receptor FcepsilonRIalpha.","date":"2001","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/11323720","citation_count":68,"is_preprint":false},{"pmid":"9398286","id":"PMC_9398286","title":"Identification of contact residues in the IgE binding site of human FcepsilonRIalpha.","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9398286","citation_count":52,"is_preprint":false},{"pmid":"10229080","id":"PMC_10229080","title":"Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid.","date":"1999","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10229080","citation_count":50,"is_preprint":false},{"pmid":"11344350","id":"PMC_11344350","title":"Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils.","date":"2001","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11344350","citation_count":46,"is_preprint":false},{"pmid":"16942574","id":"PMC_16942574","title":"The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels.","date":"2006","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/16942574","citation_count":43,"is_preprint":false},{"pmid":"23725541","id":"PMC_23725541","title":"Different FCER1A polymorphisms influence IgE levels in asthmatics and non-asthmatics.","date":"2013","source":"Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23725541","citation_count":39,"is_preprint":false},{"pmid":"11409570","id":"PMC_11409570","title":"GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells.","date":"2001","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/11409570","citation_count":36,"is_preprint":false},{"pmid":"23632296","id":"PMC_23632296","title":"Rapid polyclonal desensitization with antibodies to IgE and FcεRIα.","date":"2013","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23632296","citation_count":35,"is_preprint":false},{"pmid":"20028371","id":"PMC_20028371","title":"Analysis of the high affinity IgE receptor genes reveals epistatic effects of FCER1A variants on eczema risk.","date":"2009","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/20028371","citation_count":33,"is_preprint":false},{"pmid":"24639354","id":"PMC_24639354","title":"Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24639354","citation_count":31,"is_preprint":false},{"pmid":"14709412","id":"PMC_14709412","title":"Natural anti-FcepsilonRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria.","date":"2004","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/14709412","citation_count":30,"is_preprint":false},{"pmid":"11037968","id":"PMC_11037968","title":"Functional consequences of FcepsilonRIalpha up-regulation by IgE in human basophils.","date":"2000","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/11037968","citation_count":29,"is_preprint":false},{"pmid":"28700253","id":"PMC_28700253","title":"House Dust Mite-Induced Allergic Airway Disease Is Independent of IgE and FcεRIα.","date":"2017","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28700253","citation_count":26,"is_preprint":false},{"pmid":"30995457","id":"PMC_30995457","title":"Role of the IgE variable heavy chain in FcεRIα and superantigen binding in allergy and immunotherapy.","date":"2019","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30995457","citation_count":25,"is_preprint":false},{"pmid":"19245427","id":"PMC_19245427","title":"Common variants in FCER1A influence total serum IgE levels from cord blood up to six years of life.","date":"2009","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/19245427","citation_count":25,"is_preprint":false},{"pmid":"24354852","id":"PMC_24354852","title":"A role of FCER1A and FCER2 polymorphisms in IgE regulation.","date":"2013","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/24354852","citation_count":23,"is_preprint":false},{"pmid":"29169972","id":"PMC_29169972","title":"Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients.","date":"2017","source":"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/29169972","citation_count":21,"is_preprint":false},{"pmid":"22222815","id":"PMC_22222815","title":"Association of polymorphisms in the promoter region of FCER1A gene with atopic dermatitis, chronic uticaria, asthma, and serum immunoglobulin E levels in a Han Chinese population.","date":"2011","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22222815","citation_count":20,"is_preprint":false},{"pmid":"25412950","id":"PMC_25412950","title":"Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.","date":"2014","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/25412950","citation_count":19,"is_preprint":false},{"pmid":"11847423","id":"PMC_11847423","title":"Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils.","date":"2001","source":"Human antibodies","url":"https://pubmed.ncbi.nlm.nih.gov/11847423","citation_count":19,"is_preprint":false},{"pmid":"20141544","id":"PMC_20141544","title":"FcepsilonRIalpha gene (FCER1A) promoter polymorphisms and total serum IgE levels in Japanese atopic dermatitis patients.","date":"2010","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20141544","citation_count":19,"is_preprint":false},{"pmid":"25333273","id":"PMC_25333273","title":"A rapid method of detecting autoantibody against FcεRIα for chronic spontaneous urticaria.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25333273","citation_count":18,"is_preprint":false},{"pmid":"21356342","id":"PMC_21356342","title":"Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.","date":"2011","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21356342","citation_count":18,"is_preprint":false},{"pmid":"18726713","id":"PMC_18726713","title":"Genetic variability of the high-affinity IgE receptor alpha-subunit (FcepsilonRIalpha).","date":"2009","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/18726713","citation_count":17,"is_preprint":false},{"pmid":"26510321","id":"PMC_26510321","title":"Targeting Mast Cells and Basophils with Anti-FcεRIα Fab-Conjugated Celastrol-Loaded Micelles Suppresses Allergic Inflammation.","date":"2015","source":"Journal of biomedical nanotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/26510321","citation_count":17,"is_preprint":false},{"pmid":"16905745","id":"PMC_16905745","title":"An intermediate pH unfolding transition abrogates the ability of IgE to interact with its high affinity receptor FcepsilonRIalpha.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16905745","citation_count":17,"is_preprint":false},{"pmid":"8648137","id":"PMC_8648137","title":"Functional contributions of the FcepsilonRIalpha and FepsilonRIgamma subunit domains in FcepsilonRI-mediated signaling in mast cells.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8648137","citation_count":16,"is_preprint":false},{"pmid":"31836406","id":"PMC_31836406","title":"Rapid desensitization of humanized mice with anti-human FcεRIα monoclonal antibodies.","date":"2019","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31836406","citation_count":15,"is_preprint":false},{"pmid":"21625019","id":"PMC_21625019","title":"Comparison between sensitivity of autologous skin serum test and autologous plasma skin test in patients with Chronic Idiopathic Urticaria for detection of antibody against IgE or IgE receptor (FcεRIα).","date":"2011","source":"Iranian journal of allergy, asthma, and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21625019","citation_count":15,"is_preprint":false},{"pmid":"35197064","id":"PMC_35197064","title":"Neuronal FcεRIα directly mediates ocular itch via IgE-immune complex in a mouse model of allergic conjunctivitis.","date":"2022","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/35197064","citation_count":14,"is_preprint":false},{"pmid":"30803853","id":"PMC_30803853","title":"Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.","date":"2019","source":"Allergology international : official journal of the Japanese Society of Allergology","url":"https://pubmed.ncbi.nlm.nih.gov/30803853","citation_count":13,"is_preprint":false},{"pmid":"16272313","id":"PMC_16272313","title":"A high-affinity natural autoantibody from human cord blood defines a physiologically relevant epitope on the FcepsilonRIalpha.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16272313","citation_count":12,"is_preprint":false},{"pmid":"33326804","id":"PMC_33326804","title":"Suppression of IgE-mediated anaphylaxis and food allergy with monovalent anti-FcεRIα mAbs.","date":"2020","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33326804","citation_count":11,"is_preprint":false},{"pmid":"12752595","id":"PMC_12752595","title":"Monomeric immunoglobulin E stabilizes FcepsilonRIalpha from the human basophil cell line KU812 by protecting it from natural turnover.","date":"2003","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12752595","citation_count":11,"is_preprint":false},{"pmid":"19685047","id":"PMC_19685047","title":"FcepsilonRIalpha gene -18483A>C polymorphism affects transcriptional activity through YY1 binding.","date":"2009","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19685047","citation_count":11,"is_preprint":false},{"pmid":"11823511","id":"PMC_11823511","title":"Mutagenesis within human FcepsilonRIalpha differentially affects human and murine IgE binding.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11823511","citation_count":10,"is_preprint":false},{"pmid":"9883889","id":"PMC_9883889","title":"The membrane-proximal part of FcepsilonRIalpha contributes to human IgE and antibody binding--implications for a general structural motif in Fc receptors.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9883889","citation_count":10,"is_preprint":false},{"pmid":"31430311","id":"PMC_31430311","title":"Characterization of human FcεRIα chain expression and gene copy number in humanized rat basophilic leukaemia (RBL) reporter cell lines.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31430311","citation_count":10,"is_preprint":false},{"pmid":"30250145","id":"PMC_30250145","title":"The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30250145","citation_count":9,"is_preprint":false},{"pmid":"21209833","id":"PMC_21209833","title":"SNPs in the FCER1A gene region show no association with allergic rhinitis in a Han Chinese population.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21209833","citation_count":8,"is_preprint":false},{"pmid":"32883546","id":"PMC_32883546","title":"Interaction between functional polymorphisms in FCER1A and TLR2 and the severity of atopic dermatitis.","date":"2020","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32883546","citation_count":7,"is_preprint":false},{"pmid":"28616446","id":"PMC_28616446","title":"Treatment with anti-FcεRIα antibody exacerbates EAE and T-cell immunity against myelin.","date":"2017","source":"Neurology(R) neuroimmunology & neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/28616446","citation_count":7,"is_preprint":false},{"pmid":"23621092","id":"PMC_23621092","title":"Sex-specific differences in the relationship between the single-nucleotide polymorphism rs2298804 of FCER1A and the susceptibility to systemic lupus erythematosus in a Chinese Han population.","date":"2013","source":"Clinical and experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23621092","citation_count":7,"is_preprint":false},{"pmid":"21725845","id":"PMC_21725845","title":"A comparative search for human FcεRIα gene (FCER1A) 3'-UTR polymorphisms in Japanese and Polish populations.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21725845","citation_count":7,"is_preprint":false},{"pmid":"25239131","id":"PMC_25239131","title":"CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.","date":"2014","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25239131","citation_count":7,"is_preprint":false},{"pmid":"19584553","id":"PMC_19584553","title":"Production of human monoclonal antibodies against Fc(epsilon)RI(alpha) by a method combining in vitro immunization with phage display.","date":"2009","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19584553","citation_count":7,"is_preprint":false},{"pmid":"38757128","id":"PMC_38757128","title":"Fiber rich food suppressed airway inflammation, GATA3 + Th2 cells, and FcεRIα+ eosinophils in asthma.","date":"2024","source":"Frontiers in nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/38757128","citation_count":6,"is_preprint":false},{"pmid":"24084098","id":"PMC_24084098","title":"Identification of amino acid residues involved in the interaction of canine IgE with canine and human FcεRIα.","date":"2013","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24084098","citation_count":6,"is_preprint":false},{"pmid":"18680511","id":"PMC_18680511","title":"FCER1A gene proximal promoter polymorphisms in Caucasians and East Asians.","date":"2008","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18680511","citation_count":5,"is_preprint":false},{"pmid":"27593869","id":"PMC_27593869","title":"Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.","date":"2016","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27593869","citation_count":5,"is_preprint":false},{"pmid":"20404387","id":"PMC_20404387","title":"FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.","date":"2009","source":"Iranian journal of allergy, asthma, and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20404387","citation_count":5,"is_preprint":false},{"pmid":"35984815","id":"PMC_35984815","title":"Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria.","date":"2022","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/35984815","citation_count":4,"is_preprint":false},{"pmid":"22322186","id":"PMC_22322186","title":"Measurement for canine IgE using canine recombinant high affinity IgE receptor α chain (FcεRIα).","date":"2012","source":"The Journal of veterinary medical science","url":"https://pubmed.ncbi.nlm.nih.gov/22322186","citation_count":4,"is_preprint":false},{"pmid":"11272849","id":"PMC_11272849","title":"Direct expression of the extracellular portion of human FcepsilonRIalpha chain as inclusion bodies in Escherichia coli.","date":"2001","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11272849","citation_count":4,"is_preprint":false},{"pmid":"23675156","id":"PMC_23675156","title":"Inhibition of IgE Activity to Bind its High Affinity Receptor (FcεRIα) by Mouse Anti-IgE Cε3∼4 Monoclonal Antibody (QME5).","date":"2009","source":"International journal of biomedical science : IJBS","url":"https://pubmed.ncbi.nlm.nih.gov/23675156","citation_count":4,"is_preprint":false},{"pmid":"40204504","id":"PMC_40204504","title":"Therapeutic Efficacy of YH35324 on FcεRIα-Mediated Mast Cell/Basophil Activation.","date":"2025","source":"Allergy, asthma & immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/40204504","citation_count":3,"is_preprint":false},{"pmid":"34383238","id":"PMC_34383238","title":"Expression of FcεRIα and tryptase in human lung tissue during drug-induced anaphylactic death.","date":"2021","source":"Forensic science, medicine, and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34383238","citation_count":3,"is_preprint":false},{"pmid":"30972912","id":"PMC_30972912","title":"Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.","date":"2019","source":"Journal of viral hepatitis","url":"https://pubmed.ncbi.nlm.nih.gov/30972912","citation_count":3,"is_preprint":false},{"pmid":"39266529","id":"PMC_39266529","title":"Protection against DSS-induced colitis in mice through FcεRIα deficiency: the role of altered Lactobacillus.","date":"2024","source":"NPJ biofilms and microbiomes","url":"https://pubmed.ncbi.nlm.nih.gov/39266529","citation_count":3,"is_preprint":false},{"pmid":"37154775","id":"PMC_37154775","title":"A Co-Expressed Natural Antisense RNA FCER1A-AS Controls IgE-Dependent Immunity by Promoting Expression of FcεRIα.","date":"2023","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/37154775","citation_count":3,"is_preprint":false},{"pmid":"40534099","id":"PMC_40534099","title":"Diagnostic Use of CCR3, CD63, CD203c and FcεRIα on Blood Leukocytes of Allergic Asthma and Combined Allergic Rhinitis and Asthma Syndrome.","date":"2025","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40534099","citation_count":3,"is_preprint":false},{"pmid":"11134951","id":"PMC_11134951","title":"Expression of humanized Fab fragments that recognize the IgE-binding domain of human Fc(epsilon)RIalpha in COS and CHO cells.","date":"2001","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11134951","citation_count":3,"is_preprint":false},{"pmid":"34658711","id":"PMC_34658711","title":"IFNG, FCER1A, PCDHB10 expression as a new potential marker of efficacy in grass pollen allergen-specific immunotherapy.","date":"2021","source":"Postepy dermatologii i alergologii","url":"https://pubmed.ncbi.nlm.nih.gov/34658711","citation_count":2,"is_preprint":false},{"pmid":"34420484","id":"PMC_34420484","title":"Genetic association study of CTLA4 and FCεRIα polymorphisms in asthmatic patients in the southwestern region of Iran.","date":"2021","source":"Nucleosides, nucleotides & nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/34420484","citation_count":2,"is_preprint":false},{"pmid":"20664273","id":"PMC_20664273","title":"IgE-dependent and IgE-independent stimulation of human basophils increases the presence of immature FcεRIα by reversing degradative pathways.","date":"2010","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20664273","citation_count":2,"is_preprint":false},{"pmid":"10866125","id":"PMC_10866125","title":"Kinetic analysis of the interaction between recombinant human Fc(epsilon)RIalpha and serum IgEs from allergic patients.","date":"2000","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/10866125","citation_count":2,"is_preprint":false},{"pmid":"28667526","id":"PMC_28667526","title":"Isolation of Natural Anti-FcεRIα Autoantibodies from Healthy Donors.","date":"2017","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/28667526","citation_count":1,"is_preprint":false},{"pmid":"39290894","id":"PMC_39290894","title":"The relationship between Fc epsilon receptor-1α and β (FCER1A and FCER1B) gene polymorphisms in patients with chronic urticaria using omalizumab.","date":"2024","source":"Postepy dermatologii i alergologii","url":"https://pubmed.ncbi.nlm.nih.gov/39290894","citation_count":1,"is_preprint":false},{"pmid":"26662664","id":"PMC_26662664","title":"Treatment with Anti-FcεRIα (MAR-1) Antibody Prevents Acute Islet Allograft Rejection in a Murine Model.","date":"2015","source":"The Tokai journal of experimental and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26662664","citation_count":1,"is_preprint":false},{"pmid":"24091297","id":"PMC_24091297","title":"The role of Cε2, Cε3, and Cε4 domains in human and canine IgE and their contribution to FcεRIα interaction.","date":"2013","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24091297","citation_count":1,"is_preprint":false},{"pmid":"22800345","id":"PMC_22800345","title":"[Association analysis between single-nucleotide polymorphisms in the FCER1A gene and serum total IgE level in patients with allergic rhinitis].","date":"2012","source":"Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery","url":"https://pubmed.ncbi.nlm.nih.gov/22800345","citation_count":0,"is_preprint":false},{"pmid":"41300746","id":"PMC_41300746","title":"FCER1A Downregulation in Infectious Pneumonia: A Multi-Modal Study Combining Bioinformatics, Animal Models, and Reverse Pharmacology.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/41300746","citation_count":0,"is_preprint":false},{"pmid":"30150199","id":"PMC_30150199","title":"Report-Model studies of transmembrane interaction of FcεRIα/FcRγ reveal novel strategies to inhibit allergic responses.","date":"2018","source":"Pakistan journal of pharmaceutical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30150199","citation_count":0,"is_preprint":false},{"pmid":"28505391","id":"PMC_28505391","title":"Establishment of a novel quantum dots-encoded microbead-based flow cytometric method for quantification of soluble FcεRIα in serum.","date":"2017","source":"Cytometry. Part A : the journal of the International Society for Analytical Cytology","url":"https://pubmed.ncbi.nlm.nih.gov/28505391","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.27.644174","title":"Dendritic-cell diversity in equine blood revealed by single-cell transcriptomics","date":"2025-03-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.27.644174","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.22.634403","title":"Gene-Embedded Multi-Modal Networks for Population-Scale Multi-Omics Discovery","date":"2025-01-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.22.634403","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.18.25327658","title":"Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality","date":"2025-05-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.18.25327658","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45339,"output_tokens":5299,"usd":0.107751},"stage2":{"model":"claude-opus-4-6","input_tokens":9369,"output_tokens":2761,"usd":0.173805},"total_usd":0.281556,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"Site-directed mutagenesis of soluble FcεRIα identified K117 in the second immunoglobulin-like domain as a critical contact residue for IgE binding; K117D reduced IgE-binding affinity ~30-fold, and D159K increased affinity ~7-fold, both primarily through changes in dissociation rates, defining the IgE contact surface on FcεRIα.\",\n      \"method\": \"Site-directed mutagenesis + surface plasmon resonance (SPR) binding kinetics + circular dichroism\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with quantitative SPR kinetics and structural validation by CD\",\n      \"pmids\": [\"9398286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"IgE binding to FcεRIα upregulates cell-surface FcεRIα expression on human basophils in vitro in a dose-dependent manner; this upregulation requires IgE interaction through FcεRIα itself (blocked by anti-FcεRIα mAb CGP51901 and inhibited by dimeric IgE), and follows a linear time course over two weeks.\",\n      \"method\": \"Flow cytometry, Western blotting of whole-cell lysates, in vitro basophil culture with IgE\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (flow cytometry + Western blot + pharmacological blocking), moderate evidence\",\n      \"pmids\": [\"9473229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Anti-FcεRIα IgG autoantibodies in chronic urticaria patients activate basophil histamine release via complement (C5a receptor pathway); IgG1/IgG3 complement-fixing subtypes mediate this activity, and C5a receptor blockade or decomplementation drastically reduces histamine-releasing capacity.\",\n      \"method\": \"ELISA, Western blotting, histamine release assay, C5a receptor blockade, decomplementation\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays with pharmacological inhibition, strong mechanistic conclusion\",\n      \"pmids\": [\"9421487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Chimeric receptor experiments in RBL-2H3 cells showed that both the extracellular domain of FcεRIα and the cytoplasmic tail of FcεRIγ are essential for FcεRI-mediated signaling (inositol phosphate production, tyrosine phosphorylation, Ca2+ mobilization, histamine and arachidonic acid metabolite secretion); FcεRIα extracellular domain also modulates the magnitude of signaling events.\",\n      \"method\": \"Chimeric receptor expression in RBL-2H3 cells, inositol phosphate assay, tyrosine phosphorylation, Ca2+ mobilization, histamine/arachidonic acid secretion\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain-swap epistasis with multiple functional readouts in cell-based system\",\n      \"pmids\": [\"8648137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The IgE Cε2 domain contributes to the exceptionally long half-life of the IgE–FcεRIα complex; deletion of Cε2 from IgE Fc increases the dissociation rate from FcεRIα by >10-fold; NMR chemical shift perturbation showed Cε2 interacts directly with FcεRIα, and sedimentation equilibrium showed Cε2 also binds the Cε3-4 fragment.\",\n      \"method\": \"NMR (heteronuclear) structure determination, chemical shift perturbation, sedimentation equilibrium, dissociation kinetics\",\n      \"journal\": \"Nature structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure plus functional deletion assay and biophysical binding measurements\",\n      \"pmids\": [\"11323720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FcεRIα exists in two glycosylation states on basophils (50 kDa and 60 kDa bands); the 60 kDa band correlates with surface-expressed FcεRIα, and FcεRIβ protein levels correlate with surface FcεRIα (Spearman R=0.92), demonstrating variable FcεRIα:β stoichiometry that can be altered by IL-3 culture.\",\n      \"method\": \"Western blotting, flow cytometry, real-time PCR, IL-3 culture\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods, single laboratory\",\n      \"pmids\": [\"11344350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Upregulation of FcεRIα by IgE on basophils increases responsiveness to antigenic challenge (enhanced histamine and IL-4 release at suboptimal antigen concentrations) but is not always accompanied by coordinated upregulation of all IgE-signaling pathway components, indicating that functional upregulation can be modulated independently.\",\n      \"method\": \"Basophil culture with IgE, flow cytometry, histamine and IL-4 secretion assays, antigen dose-response\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean functional KD/KO equivalent (receptor density manipulation) with defined cellular phenotype\",\n      \"pmids\": [\"11037968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mutagenesis of human FcεRIα combined with the crystal structure identified three residues in the C-C' region of the α2 domain (K117, W130, Y131) and two in the α1 domain (R15, F17) as important for IgE binding; K117 and W130 have different effects on human vs. mouse IgE binding, indicating species-specific contact differences.\",\n      \"method\": \"Site-directed mutagenesis, SPR binding assays with human and mouse IgE\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis with quantitative binding kinetics, uses crystal structure context\",\n      \"pmids\": [\"11823511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Monomeric IgE stabilizes FcεRIα on basophils (KU812 cell line) by protecting it from temperature-dependent lysosomal turnover, without inducing intracellular signaling (no tyrosine phosphorylation or Ca2+ release); only cross-linked IgE triggers signaling.\",\n      \"method\": \"Flow cytometry, Western blotting, immunoradiometric assay, Ca2+ fluorescence (Fura-2), tyrosine phosphorylation assay\",\n      \"journal\": \"Clinical and experimental allergy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods distinguishing signaling from stabilization, in vitro reconstitution\",\n      \"pmids\": [\"12752595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The FcεRIα promoter polymorphism -344C>T increases promoter activity in mast cells (RBL-2H3 luciferase reporter assay), and the -344C allele preferentially binds transcription factor Myc-associated zinc finger protein (MAZ) as shown by EMSA, providing a molecular mechanism for differential FcεRIα expression.\",\n      \"method\": \"Luciferase reporter assay, electrophoretic mobility shift assay (EMSA)\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay (reporter) plus direct protein-DNA binding (EMSA)\",\n      \"pmids\": [\"17125826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IgE-Fc (Fcε) undergoes an unfolding transition at pH below 5.0 in its Cε3-Cε4 receptor-binding domains that abrogates interaction with FcεRIα; at neutral and mildly acidic pH (≥5.5) high-affinity binding is maintained, but interaction is lost at pH <5.0.\",\n      \"method\": \"Circular dichroism, differential scanning calorimetry, isothermal titration calorimetry, SPR-based binding assay at varying pH\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods with structural and binding data\",\n      \"pmids\": [\"16905745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The FcεRIα distal promoter polymorphism -18483A>C (rs2494262) affects transcriptional activity through differential binding of the YY1 transcription factor; the -18483C allele preferentially binds YY1, resulting in lower transcriptional activity compared to the -18483A allele.\",\n      \"method\": \"EMSA (YY1 binding preference), luciferase reporter assay\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct protein-DNA binding (EMSA) plus functional reporter assay\",\n      \"pmids\": [\"19685047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Transcription factors PU.1, GATA1, and GATA2 are required for FcεRIα (FCER1A) expression in human mast cells; ChIP showed all three bind the FCER1A promoter; siRNA knockdown of each reduces FcεRIα mRNA and surface expression, and GATA2 additionally transactivates FcεRIβ (MS4A2) promoter via direct binding verified by EMSA and luciferase assay. Knockdown of these factors also suppresses IgE-mediated degranulation.\",\n      \"method\": \"siRNA knockdown, ChIP, luciferase reporter assay, EMSA, flow cytometry, real-time PCR, degranulation assay in LAD2 cells and primary mast cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (ChIP, EMSA, reporter, functional assay) in multiple cell systems\",\n      \"pmids\": [\"24639354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The membrane-proximal FG loop (residues 154-165) of FcεRIα contributes to IgE binding; W156A mutation abolishes binding of inhibitory mAb 15/1 (which competes with IgE) but does not affect IgE binding itself, indicating distinct but overlapping epitopes within this structural motif.\",\n      \"method\": \"Site-directed mutagenesis, binding assays, peptide library phage display for epitope mapping\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional binding assays, single laboratory\",\n      \"pmids\": [\"9883889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Both IgE-dependent (anti-IgE) and IgE-independent stimulation (FMLP, C5a) of human basophils increases the immature intracellular form of FcεRIα (p46) by reversing lysosomal degradative pathways rather than increasing synthesis; IL-3 increases FcεRIα by enhancing synthesis via a distinct pathway (synergy with bafilomycin A).\",\n      \"method\": \"Western blotting, quantitative PCR, pulse-chase labeling, lysosomal inhibitor (bafilomycin A) treatment\",\n      \"journal\": \"International archives of allergy and immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pulse-chase plus pharmacological dissection of pathway, single laboratory\",\n      \"pmids\": [\"20664273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Anti-FcεRIα mAb rapid desensitization suppresses IgE-mediated anaphylaxis in mice by first decreasing mast cell FcεRI signaling, then inducing mast cell unresponsiveness by removing membrane FcεRI; this approach is safer and more durable than antigen desensitization.\",\n      \"method\": \"Mouse anaphylaxis models (active and passive), flow cytometry, histamine/mast cell protease release assays, cytokine measurement, calcium flux\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular mechanism with multiple readouts in vivo and in vitro, single group\",\n      \"pmids\": [\"23632296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FcεRIα surface expression levels correlate with co-expression of FcεRIγ in RBL reporter cell lines; stable transfection with FcεRIγ increases FcεRIα surface expression, indicating that FcεRIγ co-expression post-translationally promotes FcεRIα surface trafficking independent of gene copy number or mRNA levels.\",\n      \"method\": \"Flow cytometry with calibration microspheres, qPCR, RT-qPCR, stable transfection\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — rescue experiment with functional transfection, multiple quantitative methods\",\n      \"pmids\": [\"31430311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FcεRIα is expressed in a subpopulation of conjunctival sensory (trigeminal) neurons; IgE-immune complex directly activates these neurons and evokes ocular itch independently of conjunctival mast cell activation; neuronal-specific knockdown of FcεRIα (via AAV) significantly reduces ocular itch in an OVA-induced allergic conjunctivitis model without affecting immune cell infiltration.\",\n      \"method\": \"Calcium imaging, global FcεRIα KO mice, AAV-mediated neuronal-specific FcεRIα knockdown, behavioral itch assays, immunohistochemistry, Western blot, RT-PCR\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific genetic knockdown with behavioral and mechanistic readouts, multiple orthogonal methods\",\n      \"pmids\": [\"35197064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A natural antisense transcript (FCER1A-AS) co-expressed with FCER1A-S is required for sense transcript and FcεRIα protein expression in mast cells; CasRx-mediated knockdown of FCER1A-AS markedly decreases FCER1A-S mRNA and FcεRIα protein; FCER1A-AS-deficient mice phenocopy FcεRIα knockout mice in Schistosoma infection survival and IgE-mediated cutaneous anaphylaxis.\",\n      \"method\": \"CRISPR/CasRx knockdown, in vivo FCER1A-AS knockout mice, Schistosoma infection model, passive cutaneous anaphylaxis model, RT-PCR, Western blot\",\n      \"journal\": \"Microbiology spectrum\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with genetic rescue and in vivo phenocopy, multiple orthogonal methods\",\n      \"pmids\": [\"37154775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"YH35324, a hybrid FcεRIα extracellular domain protein, binds IgE-unoccupied FcεRIα on mast cells (LAD2), is internalized via actin-dependent endocytosis, recycled via FcRn binding in lysosomes, and suppresses FcεRIα surface expression more effectively than omalizumab in basophils from allergic patients.\",\n      \"method\": \"Flow cytometry, immunoblot, immunocytochemistry, ELISA, pharmacological inhibition of endocytosis, FcRn binding assay\",\n      \"journal\": \"Allergy, asthma & immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods defining internalization pathway, single laboratory\",\n      \"pmids\": [\"40204504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GM-CSF dose- and time-dependently reduces FcεRIα mRNA and protein expression in human mast cells (HMC-1 and cord blood-derived mast cells) in vitro, accompanied by decreased histamine levels and tryptase activity, demonstrating that GM-CSF selectively inhibits mast cell differentiation markers including FcεRIα.\",\n      \"method\": \"mRNA analysis, immunoreactivity staining, intracellular histamine/tryptase assay, in vitro mast cell culture\",\n      \"journal\": \"Archives of dermatological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple readouts in two cell systems, single laboratory\",\n      \"pmids\": [\"11409570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CD72 agonistic antibody (K10.6) induces phosphorylation of the ubiquitin ligase Cbl-b and decreases FcεRIα (and KIT) surface expression on mouse bone marrow-derived mast cells, suppressing IgE-triggered degranulation; this mechanism is species-dependent (different from human mast cells where CD72 does not suppress IgE/FcεRI responses).\",\n      \"method\": \"Flow cytometry, Western blotting (Cbl-b phosphorylation), IgE-triggered degranulation assay, agonistic antibody treatment\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway identification with functional readout, single laboratory\",\n      \"pmids\": [\"25239131\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FcεRIα is the IgE-binding α-subunit of the tetrameric high-affinity IgE receptor (FcεRI); its second extracellular immunoglobulin-like domain (particularly K117, W130, Y131) and membrane-proximal regions form the IgE contact surface, while the IgE Cε2 domain stabilizes the complex and slows dissociation; surface expression is transcriptionally controlled by PU.1, GATA1, and GATA2, post-transcriptionally stabilized by monomeric IgE through prevention of lysosomal turnover, regulated by a co-expressed natural antisense transcript (FCER1A-AS), and requires co-expression of FcεRIγ for efficient surface trafficking; FcεRIα mediates mast cell and basophil activation upon IgE cross-linking (requiring both its extracellular domain and the FcεRIγ cytoplasmic tail for full signaling), and also functions directly in sensory neurons to mediate IgE-IC-evoked itch independently of mast cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FCER1A encodes the IgE-binding α-subunit of the high-affinity IgE receptor (FcεRI), serving as the primary determinant of IgE recognition on mast cells, basophils, and a subset of sensory neurons, thereby coupling humoral IgE to cellular effector responses in allergy and immunity. The IgE-binding interface maps to the second extracellular immunoglobulin-like domain — particularly residues K117, W130, and Y131 — while the IgE Cε2 domain stabilizes the complex by slowing dissociation more than 10-fold [PMID:9398286, PMID:11823511, PMID:11323720]. Surface expression of FcεRIα is transcriptionally driven by PU.1, GATA1, and GATA2 and post-transcriptionally stabilized by monomeric IgE, which prevents lysosomal turnover without triggering signaling; efficient surface trafficking additionally requires co-expression of FcεRIγ, and a co-expressed natural antisense transcript (FCER1A-AS) is essential for sense mRNA and protein production [PMID:24639354, PMID:12752595, PMID:31430311, PMID:37154775]. Beyond canonical mast cell/basophil activation, FcεRIα expressed on trigeminal sensory neurons directly mediates IgE-immune-complex-evoked itch independently of mast cells [PMID:35197064].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing that FcεRIα's extracellular domain and FcεRIγ's cytoplasmic tail are both required for full IgE-mediated signaling resolved the division of labor within the receptor complex — ligand recognition versus signal transduction.\",\n      \"evidence\": \"Chimeric receptor domain-swap experiments in RBL-2H3 cells with multiple functional readouts (IP production, Ca²⁺, degranulation)\",\n      \"pmids\": [\"8648137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of α–γ interface\", \"Contribution of FcεRIβ to signaling not resolved in this system\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identification of K117 as a critical IgE-contact residue defined the molecular binding interface on FcεRIα's α2 domain and showed that affinity is governed primarily by dissociation kinetics.\",\n      \"evidence\": \"Site-directed mutagenesis of soluble FcεRIα with quantitative SPR kinetics\",\n      \"pmids\": [\"9398286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full binding footprint not yet mapped\", \"No crystal structure of complex at this time\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that IgE itself upregulates FcεRIα surface expression on basophils established a positive-feedback loop between circulating IgE and receptor density, directly relevant to allergic sensitization.\",\n      \"evidence\": \"Flow cytometry and Western blot of basophils cultured with graded IgE concentrations, with anti-FcεRIα blocking\",\n      \"pmids\": [\"9473229\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of upregulation (stabilization vs. synthesis) not yet distinguished\", \"In vivo confirmation lacking\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing that the IgE Cε2 domain directly contacts FcεRIα and slows dissociation >10-fold explained the exceptionally long half-life of the IgE–FcεRI complex.\",\n      \"evidence\": \"NMR chemical shift perturbation, sedimentation equilibrium, and dissociation kinetics of Cε2-deleted IgE-Fc\",\n      \"pmids\": [\"11323720\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of Cε2–FcεRIα interface not determined\", \"Role of Cε2 in allergen cross-linking geometry unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Expanding the IgE contact map to W130 and Y131 and demonstrating species-specific differences refined the binding-surface model and informed therapeutic targeting of the α2 domain.\",\n      \"evidence\": \"Crystal-structure-guided mutagenesis with SPR using human and mouse IgE\",\n      \"pmids\": [\"11823511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Energetic contributions of individual contacts not fully decomposed\", \"No co-crystal with bound IgE at atomic resolution at this point\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Distinguishing stabilization from signaling resolved how monomeric IgE increases FcεRIα density: IgE protects FcεRIα from lysosomal degradation without triggering activation, whereas only cross-linked IgE initiates signaling.\",\n      \"evidence\": \"Flow cytometry, Ca²⁺ flux, tyrosine phosphorylation assays, and lysosomal degradation studies in KU812 cells\",\n      \"pmids\": [\"12752595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact lysosomal sorting signals on FcεRIα not identified\", \"Whether stabilization involves conformational change or steric shielding unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying the -344C>T promoter polymorphism and its differential binding of transcription factor MAZ provided the first molecular mechanism for genetically encoded variation in FcεRIα expression levels.\",\n      \"evidence\": \"Luciferase reporter assay and EMSA in RBL-2H3 cells\",\n      \"pmids\": [\"17125826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance to atopic disease risk not functionally validated\", \"Interaction with other promoter-bound factors not examined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that PU.1, GATA1, and GATA2 each bind the FCER1A promoter and are individually required for FcεRIα expression and IgE-mediated degranulation established the core transcription factor network controlling receptor expression in human mast cells.\",\n      \"evidence\": \"ChIP, EMSA, luciferase reporter, siRNA knockdown with flow cytometry and degranulation assays in LAD2 and primary mast cells\",\n      \"pmids\": [\"24639354\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Combinatorial logic of PU.1/GATA cooperativity not dissected\", \"Epigenetic regulation of the locus not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing that FcεRIγ co-expression is required for efficient FcεRIα surface trafficking independently of mRNA levels resolved the post-translational bottleneck in receptor assembly.\",\n      \"evidence\": \"Stable transfection of FcεRIγ into RBL reporter cells with calibrated flow cytometry and qPCR\",\n      \"pmids\": [\"31430311\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct α–γ interaction interface not mapped\", \"Role of FcεRIβ in trafficking not examined in this system\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery that FcεRIα is expressed on trigeminal sensory neurons and directly mediates IgE-immune-complex-evoked itch independently of mast cells expanded the receptor's functional repertoire beyond immune cells.\",\n      \"evidence\": \"Calcium imaging, global FcεRIα KO mice, AAV-mediated neuronal-specific knockdown, and behavioral itch assays in allergic conjunctivitis model\",\n      \"pmids\": [\"35197064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream neuronal signaling pathway not defined\", \"Whether neuronal FcεRI contains β/γ subunits unknown\", \"Relevance to non-ocular itch or pain not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Establishing that a natural antisense transcript (FCER1A-AS) is essential for FCER1A sense mRNA and protein expression — with knockout mice phenocopying FcεRIα deficiency — revealed a non-coding RNA layer of receptor regulation.\",\n      \"evidence\": \"CasRx knockdown in mast cells plus FCER1A-AS knockout mice tested in Schistosoma infection and passive cutaneous anaphylaxis models\",\n      \"pmids\": [\"37154775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of antisense-mediated stabilization (RNA duplex, chromatin, or splicing) not defined\", \"Tissue specificity of antisense regulation not characterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic-resolution mechanism by which FCER1A-AS stabilizes sense mRNA, the downstream signaling pathway in sensory neurons, the structural basis of the FcεRIα–γ assembly interaction, and whether neuronal FcεRI assembles with β and γ subunits.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Neuronal FcεRI subunit composition unknown\", \"Antisense RNA mechanism of action uncharacterized\", \"No high-resolution structure of full tetrameric receptor in membrane context\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3, 7, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 5, 6, 16, 19]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [8, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 3, 6, 12, 15, 17]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 6, 8, 17]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [9, 11, 12, 18]}\n    ],\n    \"complexes\": [\n      \"FcεRI (high-affinity IgE receptor tetramer: αβγ2)\"\n    ],\n    \"partners\": [\n      \"FCER1G\",\n      \"MS4A2\",\n      \"IGHE\",\n      \"PU.1\",\n      \"GATA1\",\n      \"GATA2\",\n      \"MAZ\",\n      \"YY1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}